Amedica used its FDA-approved Silicon Nitride material to develop a spine implant designed to provide increased longevity, better osteointegration and reduced infection rates over traditional metal-on-plastic or metal-on-metal designs, according to the release.
The company currently focuses on spinal and reconstructive medical device manufacturing. Executives are looking to expand its Silicon Nitride offerings beyond spinal fusion to hip and knee replacements, dental implants and suture anchors, according to the news release.
More Articles on Devices:
SpineGuard Receives Russian Approval for PediGuard Spine Device
Premia Spine Develops Spine Implant Alternative to Fusion
Ascendx Spine Recognized by Southeast Medical Device Association
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.